Skip to main content
Erschienen in: Diabetologia 12/2009

01.12.2009 | Article

Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset

verfasst von: Y. Kawabata, H. Ikegami, T. Awata, A. Imagawa, T. Maruyama, E. Kawasaki, S. Tanaka, A. Shimada, H. Osawa, T. Kobayashi, T. Hanafusa, K. Tokunaga, H. Makino, on behalf of the Committee on Type 1 Diabetes, Japan Diabetes Society

Erschienen in: Diabetologia | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Aim/hypothesis

We sought to clarify similarities and differences in the contribution of HLA to genetic susceptibility to three subtypes of type 1 diabetes: acute-onset, fulminant and slowly progressive.

Methods

We genotyped 545 Japanese patients with type 1 diabetes (338 acute-onset, 80 fulminant, 127 slowly progressive) and 396 control participants at HLA-DRB1, -DQB1, -A, -B and -C, and at 101 candidate single nucleotide polymorphisms (SNPs) in an 8.5 Mb region of the extended HLA.

Results

DRB1*0405-DQB1*0401, DRB1*0802-DQB1*0302 and DRB1*0901-DQB1*0303 were associated with acute-onset type 1 diabetes, with the DRB1*0405-DQB1*0401/DRB1*0802-DQB1*0302 genotype achieving the highest odds ratio of 42.7. DRB1*1501-DQB1*0602 and DRB1*1502-DQB1*0601 were negatively associated with acute-onset type 1 diabetes. A similar tendency was observed for slowly progressive type 1 diabetes. In contrast, only DRB1*0405-DQB1*0401 was associated with fulminant type 1 diabetes, with the DRB1*0405-DQB1*0401/DRB1*0405-DQB1*0401 genotype showing the highest odds ratio of 11.2. DRB1*0802-DQB1*0302, DRB1*0405-DQB1*0401/DRB1*0802-DQB1*0302 and DRB1*1501-DQB1*0602 were not associated with fulminant type 1 diabetes. The association of class I alleles and a panel of SNPs in an extended HLA region with fulminant type 1 diabetes was also different from that seen for the acute-onset and slowly progressive forms. The presence of both one and two susceptible haplotypes conferred susceptibility to slowly progressive type 1 diabetes, whereas the presence of two susceptible haplotypes was required to confer susceptibility to acute-onset and fulminant type 1 diabetes.

Conclusions/interpretation

These data suggest that HLA associations with fulminant type 1 diabetes are qualitatively different from those with other subtypes of type 1 diabetes, whereas the HLA contribution to slowly progressive type 1 diabetes is qualitatively similar to, but quantitatively different from, that in acute-onset type 1 diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342:301–307CrossRefPubMed Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342:301–307CrossRefPubMed
2.
Zurück zum Zitat Imagawa A, Hanafusa T (2007) Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Prac Endocrinol Metab 3:36–45 Imagawa A, Hanafusa T (2007) Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Prac Endocrinol Metab 3:36–45
3.
Zurück zum Zitat Cho YM, Kim JT, Ko KS et al (2007) Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 50:2276–2279CrossRefPubMed Cho YM, Kim JT, Ko KS et al (2007) Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 50:2276–2279CrossRefPubMed
4.
Zurück zum Zitat Kobayashi T, Tamemoto K, Nakanishi K et al (1993) Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780–788CrossRefPubMed Kobayashi T, Tamemoto K, Nakanishi K et al (1993) Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780–788CrossRefPubMed
5.
Zurück zum Zitat Todd J, Bell JI, MacDevitt HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599–604CrossRefPubMed Todd J, Bell JI, MacDevitt HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599–604CrossRefPubMed
6.
Zurück zum Zitat Imagawa A, Hanafusa T, Uchigata Y et al (2005) Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48:294–300CrossRefPubMed Imagawa A, Hanafusa T, Uchigata Y et al (2005) Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48:294–300CrossRefPubMed
7.
Zurück zum Zitat Bannai M, Higuchi K, Akesaka T et al (2004) Single-nucleotide-polymorphism genotyping for whole-genome-amplified samples using automated fluorescence correlation spectroscopy. Anal Biochem 327:215–221CrossRefPubMed Bannai M, Higuchi K, Akesaka T et al (2004) Single-nucleotide-polymorphism genotyping for whole-genome-amplified samples using automated fluorescence correlation spectroscopy. Anal Biochem 327:215–221CrossRefPubMed
8.
Zurück zum Zitat Ikegami H, Kawaguchi Y, Yamato E et al (1992) Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75:1381–1385CrossRefPubMed Ikegami H, Kawaguchi Y, Yamato E et al (1992) Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75:1381–1385CrossRefPubMed
9.
Zurück zum Zitat Awata T, Kuzuya T, Matsuda A et al (1992) Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35:419–424CrossRefPubMed Awata T, Kuzuya T, Matsuda A et al (1992) Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35:419–424CrossRefPubMed
10.
Zurück zum Zitat Kawabata Y, Ikegami H, Kawaguchi Y et al (2002) Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51:545–551CrossRefPubMed Kawabata Y, Ikegami H, Kawaguchi Y et al (2002) Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51:545–551CrossRefPubMed
11.
Zurück zum Zitat Murao S, Makino H, Kaino Y et al (2004) Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 53:2684–2690CrossRefPubMed Murao S, Makino H, Kaino Y et al (2004) Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 53:2684–2690CrossRefPubMed
12.
Zurück zum Zitat Saito S, Ota S, Yamada E, Inoko H, Ota M (2000) Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56:522–529CrossRefPubMed Saito S, Ota S, Yamada E, Inoko H, Ota M (2000) Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56:522–529CrossRefPubMed
13.
Zurück zum Zitat Moreau C, Drui D, Arnault-Ouary G, Charnonnel B, Chaillous L, Cariou B (2008) Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab 34:529–532CrossRefPubMed Moreau C, Drui D, Arnault-Ouary G, Charnonnel B, Chaillous L, Cariou B (2008) Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab 34:529–532CrossRefPubMed
14.
Zurück zum Zitat Imagawa A, Hanafusa T (2006) Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud 3:169–177CrossRefPubMed Imagawa A, Hanafusa T (2006) Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud 3:169–177CrossRefPubMed
15.
Zurück zum Zitat Imagawa A, Hanafusa T, Makino H, Miyagawa JI, Juto P (2005) High titres of IgA antibodies to enterovirus in fulminant type 1 diabetes. Diabetologia 48:290–293CrossRefPubMed Imagawa A, Hanafusa T, Makino H, Miyagawa JI, Juto P (2005) High titres of IgA antibodies to enterovirus in fulminant type 1 diabetes. Diabetologia 48:290–293CrossRefPubMed
16.
Zurück zum Zitat Shimada A, Maruyama T (2004) Encephalomyocarditis-virus-induced diabetes model resembles "fulminant" type 1 diabetes in humans. Diabetologia 47:1854–1855CrossRefPubMed Shimada A, Maruyama T (2004) Encephalomyocarditis-virus-induced diabetes model resembles "fulminant" type 1 diabetes in humans. Diabetologia 47:1854–1855CrossRefPubMed
17.
Zurück zum Zitat Mineta M, Tanimura M, Tana T, Yssel H, Kashiwagi S, Sasazuki T (1996) Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 8:525–531CrossRefPubMed Mineta M, Tanimura M, Tana T, Yssel H, Kashiwagi S, Sasazuki T (1996) Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 8:525–531CrossRefPubMed
18.
Zurück zum Zitat Zimmet PZ, Tuomi T, Mackay IR et al (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299–303CrossRefPubMed Zimmet PZ, Tuomi T, Mackay IR et al (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299–303CrossRefPubMed
19.
Zurück zum Zitat Zavattari P, Lampis R, Motzo C et al (2001) Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 disease risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet 10:881–889CrossRefPubMed Zavattari P, Lampis R, Motzo C et al (2001) Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 disease risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet 10:881–889CrossRefPubMed
Metadaten
Titel
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset
verfasst von
Y. Kawabata
H. Ikegami
T. Awata
A. Imagawa
T. Maruyama
E. Kawasaki
S. Tanaka
A. Shimada
H. Osawa
T. Kobayashi
T. Hanafusa
K. Tokunaga
H. Makino
on behalf of the Committee on Type 1 Diabetes, Japan Diabetes Society
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 12/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1539-9

Weitere Artikel der Ausgabe 12/2009

Diabetologia 12/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.